StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Barclays Upgrades Bristol-Myers Squibb Co. (BMY) to Overweight
May 3, 2019 4:40 AM
Barclays analyst Geoff Meacham upgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Equalweight to Overweight with a price target of $55.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Hot Comments
Hot Upgrades
Upgrades
